Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials

D. Rosenberg*, T. Avni, G. Tsvetov, A. Gafter-Gvili, T. Diker-Cohen

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2131
Number of pages1
JournalOsteoporosis International
Issue number10
StatePublished - Oct 2021

Cite this